PUMA BIOTECHNOLOGY INC (PBYI) Stock Income Statement
NASDAQ:PBYI - Nasdaq - US74587V1070 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 230.47M | 235.64M | 228.00M | 253.20M | 225.10M | |||
| Cost Of Goods | 64.40M | 62.68M | 55.10M | 63.70M | 39.40M | |||
| Gross Profit | 166.06M | 172.96M | 172.90M | 189.50M | 185.70M | |||
| Operating Expenses | 135.10M | 139.69M | 149.20M | 188.20M | 216.10M | |||
| Research and Development | 54.94M | 50.38M | 59.20M | 71.90M | 97.70M | |||
| Selling, General, and Administrative Expenses | 80.16M | 89.31M | 90.00M | 116.30M | 118.50M | |||
| Operating Income | 30.97M | 33.27M | 23.80M | 1.30M | -30.40M | |||
| Interest Income/Expense | -7.73M | -10.72M | -10.80M | -12.60M | -13.60M | |||
| Other Income/Expense | 862.00K | 759.00K | 0.00 | 300.00K | 400.00K | |||
| Non Recurring Items | 0.00 | -625.00K | -12.50M | -17.70M | -16.20M | |||
| Income Before Taxes | 24.10M | 22.67M | 500.00K | -28.80M | -59.80M | |||
| Income Tax | -6.18M | 1.08M | 500.00K | 300.00K | 200.00K | |||
| Net Income | 30.28M | 21.59M | 0.00 | -29.10M | -60.00M | |||
| EBITDA | 42.49M | 44.78M | 32.72M | 11.90M | -20.37M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.62 | 0.45 | 0.00 | -0.72 | -1.52 | |||
| Non GAAP EPS | 0.61 | 0.46 | -0.00 | -0.53 | -1.52 | |||
| Statistics | ||||||||
| Gross Profit Margin | 72.06% | 73.40% | 75.83% | 74.84% | 82.50% | |||
| Profit Margin | 13.14% | 9.16% | N/A | -11.49% | -26.65% | |||
| Operating Profit Margin | 13.44% | 14.12% | 10.44% | 0.51% | -13.51% | |||
All data in USD